Home >> Proteins >> CD Antigens

CD Antigens(CD抗原)

Cell surface antigens of leukocytes are called CD antigens, and important for immune reactions of organisms. As lymphocytes mature, they express different protein receptors on the cell surface, which can aid in determining the type and maturation stage of the cells being examined. These proteins or antigen markers are called Clusters of Differentiation

The term CD means a cluster of differentiation OR a cluster of determinants which indicates the lineage or maturational stage of lymphocytes. During the course of development from precursor cells into functionally mature forms, lymphocytes display a complex pattern of surface antigens, some of which are acquired at certain stages while others are lost.

These surface antigens were identified initially by monoclonal antibodies and the designations of the antibodies were used often as synonyms for the cell surface proteins they detected, giving rise to a plethora of different names. CD antigens are present on some subpopulations and functional types of leukocytes. CD antigens participate in immune reaction as receptors for cell communication (e.g. adherence molecules, antigen recognizing receptors).

CD antigen nomenclature describes different monoclonal antibodies from different sources that recognize identical antigens. Numbers are assigned arbitrarily. A small letter w before the number designation stands for "workshop". It indicates that the CD designation is tentative.

CD antigens are found on practically all known cell types. In some cases CD antigens are expressed only at certain stages of development or under certain conditions, for example after cell activation or in certain disease conditions. In Hematology the morphological criteria is for the description of specific developmental stages of lymphocytes unlike in CD antigens which the use of monoclonal antibodies allows the objective and precise analysis and standardized typing of mature and immature normal and malignant cells of all hematopoietic cell lineages. The use antibodies also helps to delineate the biologic traits that distinguish normal immune and hematopoietic cells from their malignant counterparts, which is utmost important in the understanding of hematological malignancies.

The expression of CD antigens is influenced by cytokines, such as binding of ligands to CD antigens which has shown to modulate the expression of cytokines. CD antigens have been shown to be identical with receptors of cytokines such as CD25 (TAC antigen).

CD antigens appear to carry out cytokine receptor-like functions such as CD27, CD30 and CD40. CD antigens are involved in modulating the biological activities of cytokines such as CD4, CD28 and CD40. CD antigens exist also in soluble forms for example CD14, CD21, CD23, CD27, CD100 and CD137.

The CD Antigen’s designation isn’t related to the biological function, thus CD antigens include receptors, glycans, adhesion molecules, membrane-bound enzymes, etc.

The most commonly know CD antigens are CD4 and CD8 which are markers for T-helper and T-suppressor cells, respectively. CD4 binds to relatively invariant sites on class II major histocompatibility complex molecules outside the peptide-binding groove, which interacts with the T-cell receptor. CD4 is also the central docking receptor for human immunodeficiency virus. CD8 binds to relatively invariant sites on class I major histocompatibility complex molecules outside the peptide-binding groove. CD8 is also expressed on a subset of dendritic cells. Other more important CD antigens include the leukocytes integrins (CD11/CD18) and the hematopoietic stem cell marker CD34.

CD69 is homologous to members of a supergene family of type II integral membrane proteins having C-type lectin domains. Although the precise functions of the CD-69 antigen is not known, evidence suggests that these proteins transmit mitogenic signals across the plasma membrane and are up- regulated in response to lymphocyte activation

In the last decade the wide palette of monoclonal antibodies has been prepared which recognise of CD antigens on human cells. Much less monoclonal antibodies are available specific for typing of domestic animal cells. CD antigens have been characterized as both transmembrane proteins and cell surface proteins anchored to the plasma membrane via covalent attachment to fatty acid-containing glycolipids such as glycosylphosphatidylinositol (GPI).

Products for  CD Antigens

  1. Cat.No. 产品名称 Information
  2. GC74548 Flotetuzumab

    伏妥珠单抗; MGD006; S80880

    Flotetuzumab(MGD006;S80880)是一种正在研究的CD123/CD3双特异性双亲和力再靶向抗体(DART)分子。
  3. GC69127 Foralumab

    NI-0401

    Foralumab (NI-0401) 是一种口服有效的人源化单克隆抗体,靶向 CD3。Foralumab 可调节 NSG 小鼠中由人类造血干细胞重建的人类细胞的免疫反应。
  4. GC73334 Glutaminyl cyclases-IN-1

    IsoQC-IN-1

    Glutaminyl cyclases-IN-1(IsoQC-IN-1)是一种强效的谷氨酰胺环化酶(QC)抑制剂,对人类QC和IsoQC的IC50值分别为12 nM和73 nM。
  5. GC74494 Gresonitamab

    AMG 910; Anti-Human CD3xClaudin18 2

    Gresonitamab(AMG 910)是一种半衰期延长(HLE)双特异性T细胞接合剂(BiTE)抗体,靶向CD3阳性T细胞和CLDN18.2表达的肿瘤细胞。
  6. GP23696 IGLL1 Human Immunoglobulin Lambda-Like Polypeptide 1 Human Recombinant
  7. GC74571 Ligufalimab

    莱法利单抗; AK 117

    Ligufalimab(AK 117)是一种人源化IgG4抗CD47单克隆抗体。
  8. GC74604 Linvoseltamab

    利伏赛坦单抗; REGN5458

    Linvoseltamab是一种针对BCMA (TNFRSF17)和CD3 epsilon的双特异性抗体。
  9. GC73846 MA3 aptamer sodium MA3 aptamer sodium是一个86碱基长的DNA适体,靶向粘蛋白MUC1。
  10. GC69453 MethADP triammonium

    Adenosine 5'-(α,β-methylene)diphosphate triammonium

    MethADP (Adenosine 5'-(α,β-methylene)diphosphate) triammonium 是一种 CD73 抑制剂。MethADP 可用于 ATP-腺苷通路的研究。
  11. GC74576 Mezagitamab

    迈泽妥单抗; TAK-079

    Mezagitamab(TAK-079)是一种IgG1λ抗CD38单克隆抗体。
  12. GC74581 Modakafusp alfa

    TAK-573

    Modakafusp alfa (TAK-573)是一种人源化的抗cd38 IgG4单克隆抗体,与2个减毒的IFNα2b分子融合,将干扰素- α传递到表达cd38的细胞。
  13. GP23966 MS4A1 Human Membrane Spanning 4-Domains A1 Human Recombinant
  14. GP23964 MSR1 Human Macrophage Scavenger Receptor 1 Human Recombinant
  15. GP23965 MSR1 Human, sf9 Macrophage Scavenger Receptor 1, sf9 Human Recombinant
  16. GC68344 Mupadolimab

    CPI-006

    Mupadolimab (CPI-006) 是一种 IgG1κ 人源化的 FcγR 结合缺陷抗 CD73 单抗,激活 CD73POS B 细胞。
  17. GC69512 Muromonab

    Muromonab 是一种靶向 CD3 受体的单克隆抗体。Muromonab 可以阻断所有细胞毒性 T 细胞功能。Muromonab 也作为一种免疫抑制剂用于减少急性实体器官移植排斥反应。

  18. GC74582 Nivatrotamab

    Hu3F8-BsAb

    Nivatrotamab (Hu3F8-BsAb)是人源抗gd2 /CD3双特异性抗体。
  19. GP24069 NT5E (CD73) Human 5'-Nucleotidase Ecto (CD73) Human Recombinant
  20. GP24070 NT5E (CD73) Mouse 5'-Nucleotidase Ecto (CD73) Mouse Recombinant
  21. GC74585 Obexelimab

    奥贝利单抗; XmAb5871

    Obexelimab(XmAb5871)是一种人源化抗CD19抗体。
  22. GC74586 Obrindatamab

    MGD009

    Obrindatamab是一种人源化抗B7-H3/CD3双特异性抗体。
  23. GC65470 Oleclumab

    奥来鲁单抗,MEDI9447

    Oleclumab (MEDI9447) 是一种人 IgG1Λ 抗 CD73 单克隆抗体,可抑制 CD73 功能。Oleclumab 具有抗肿瘤活性。
  24. GC74589 Ontorpacept

    TTI-621

    Ontorpacept (TTI-621)是一种可溶性融合蛋白,由与人IgG1 Fc区连接的人SIRPα n端(1-118)组成。
  25. GC62694 OP-5244 OP-5244 是一种有效和具有口服活性的 CD73 抑制剂,IC50 值为 0.25 nM。OP-5244 通过阻断腺苷的产生来逆转免疫抑制作用,具有进行癌症研究的潜力。
  26. GC62695 OP-5244 sodium OP-5244 sodium 是一种有效和具有口服活性的 CD73 抑制剂,IC50 值为 0.25 nM。OP-5244 sodium 通过阻断腺苷的产生来逆转免疫抑制作用,具有进行癌症研究的潜力。
  27. GC72342 Otelixizumab Otelixizumab(ChAglyCD3)是一种抗人CD3单克隆抗体,可用于1型糖尿病的研究。
  28. GC74591 Pacanalotamab

    AMG 420; BI-836909

    Pacanalotamab (amg 420;BI-836909)是一种靶向BCMA和CD3E的双特异性t细胞接合剂(BiTE)。
  29. GC74593 Pasotuxizumab

    帕妥昔珠单抗; BAY 2010112; AMG 212

    Pasotuxizumab (BAY 2010112)是一种PSMA和CD3双特异性t细胞接合器(BiTE)。
  30. GC72443 Pavurutamab Pavurutamab (AMG-701)是一种抗cd3和抗b细胞成熟抗原(BCMA)的双特异性T细胞接合分子。
  31. GC74588 Plamotamab

    帕拉莫妥单抗; XmAb-13676

    Plamotamab(XmAb-13676)是一种结合CD3和CD20的人双特异性抗体(bsAb)。
  32. GP23021 sCD23 Human Soluble CD23 Human Recombinant
  33. GP20872 sCD40L Human Soluble CD-40 Ligand/TRAP Human Recombinant
  34. GP20873 sCD40L Human, His 可溶性 CD40 配体/TRAP 人类重组体,His 标签
  35. GP26070 sCD40L Human, His Active sCD40L Human Recombinant produced in E
  36. GP20874 sCD40L Mouse Soluble CD-40 Ligand/TRAP Mouse Recombinant
  37. GP20875 sCD40L Mouse, sf9 soluble CD40 Ligand/TRAPMouse Recombinant, sf9
  38. GC69894 Siplizumab

    MEDI-507

    Siplizumab (MEDI-507) 是一种抗 CD2 的人源化 IgG1 单克隆抗体。Siplizumab 可耗尽 T 细胞、降低 T 细胞活化、抑制 T 细胞增殖并富集 naÏve 和 bona fide 调节性 T 细胞。
  39. GC74539 Solitomab

    索利托单抗; AMG 110; MT110

    Solitomab(AMG 110)是一种双特异性抗CD3和抗上皮细胞粘附分子(EpCAM)抗体。
  40. GC74624 Surzebiclimab

    BGB-A425

    Surzebiclimab (BGB-A425)是一种人源化igg1变异单克隆抗体,抗t细胞免疫球蛋白和粘蛋白结构域-3 (TIM-3)。
  41. GC69985 Talquetamab

    JNJ-64407564

    Talquetamab(JNJ-64407564)是一种人源化的双特异性抗体,可与 GPRC5D (G 蛋白偶联受体家族C5组成员 D) 和 CD3 结合,通过T 细胞的募集和活化诱导 T 细胞介导的杀死表达 GPRC5 的 MM 细胞。Talquetamab(JNJ-64407564)具有抗肿瘤活性。
  42. GC74498 Teclistamab

    特立妥单抗

    Teclistamab是一种针对BCMA和CD3的人双特异性抗体,其识别靶细胞上的BCMA和T细胞上的CD3,并诱导T细胞介导的细胞毒性,导致T细胞活化和随后的靶细胞裂解。
  43. GC70011 Teplizumab

    MGA-031; PRV-031

    Teplizumab (MGA-031) 是一种 Fc 受体型、非结合类型的抗-人 CD3 的单克隆抗体。Teplizumab 可缓解 β 细胞的功能丧失。Teplizumab 可用于 type 1 型糖尿病的研究。
  44. GC74497 Tepoditamab

    MCLA 117

    Tepoditamab (MCLA-117)是一种双特异性单克隆抗体,可结合骨髓细胞的clecl12a和细胞毒性T细胞的CD3。
  45. GC74530 Ubamatamab

    乌巴妥单抗; REGN4018

    Ubamatamab(REGN4018)是一种针对粘蛋白16(MUC16)和CD3的人源化双特异性抗体。
  46. GC68346 Uliledlimab

    TJ004309

    Uliledlimab 是一种有效的抗 CD73 人源单克隆抗体。Uliledlimab 抑制胞外单磷酸腺苷 (AMP) 向腺苷的转化。Uliledlimab 可用于癌症的研究。
  47. GC74528 Urabrelimab

    SRF-231; SRF231

    Urabrelimab(SRF231)是一种阻断CD47-SIRP相互作用的全人源性抗CD47单克隆抗体。
  48. GC74526 Vepsitamab

    维斯妥单抗; AMG 199

    Vepsitamab(AMG 199)是一种抗MUC17/CD3 BiTE抗体,与T细胞上的CD3和肿瘤细胞上表达的MUC17结合,介导重定向的肿瘤细胞裂解,并诱导T细胞活化和增殖。
  49. GC74525 Vibecotamab

    维克妥单抗; XmAb14045

    Vibecotamab (XmAb14045)是一种有效的针对CD123和CD3的双特异性抗体,可刺激T细胞介导的靶向杀伤表达CD123的细胞。
  50. GC74449 Vonsetamig Vonsetamig是一种人源免疫球蛋白G4-kappa,抗tnfrsf17和CD3E单克隆抗体。
  51. GC74524 Voxalatamab

    沃昔莱妥单抗; JNJ-63898081

    Voxalatamab(JNJ-63898081)是一种结合PSMA和CD3的双特异性IgG4抗体,具有抗癌活性,用于癌症研究。

Items 151 to 200 of 200 total

per page
  1. 1
  2. 2
  3. 3
  4. 4

Set Descending Direction